Alexion Pharma (ALXN) to Resume Trading at 5 PM ET
- Wall St opens higher as more earnings roll in
- JPMorgan is worried about further S&P 500 sell-off potential
- Oil falls back after robust EU data as Mideast tensions linger
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- SAP Q1 results fall short of Wall Street estimates as transformation kicks off
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Kroger (KR), Albertsons and C&S Wholesale Grocers Announce an Updated and Expanded Divestiture Plan
- Costar Group (CSGP) to Acquire Matterport (MTTR) for $5.50/sh Cash and Stock
- Jaguar Health (JAGX) Files $75M Mixed Shelf
- Apple (AAPL) PT Lowered to $210 at Morgan Stanley, 'We'd buy post-earnings weakness'
- Apple, PepsiCo, JetBlue fall premarket; Amazon, GM and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
Alexion Pharma (ALXN) Offers Update on 10-Q Submission; Says Investigating Soliris Sales Practices
November 9, 2016 4:32 PM ESTAlexion Pharmaceuticals, Inc. (Nasdaq: ALXN) announced that it has filed with the U.S. Securities and Exchange Commission (SEC) a Form 12b-25 Notification of Late Filing with regard to its Quarterly Report on Form 10-Q for the quarter ended September 30, 2016.
The Audit and Finance Committee of the Board of Directors is... More
Alexion Pharma (ALXN) Files to Delay Form 10-Q; Notes Investigation of Sales Practices
November 9, 2016 4:27 PM ESTAlexion Pharma (Nasdaq: ALXN) filed to delay Form 10-Q. The company noted the following:
The Audit and Finance Committee of the Board of Directors of Alexion... More
Alexion Pharma (ALXN) Halted, News Pending
November 9, 2016 4:19 PM ESTAlexion Pharma (NASDAQ: ALXN) Halted, News Pending
... More